Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of Chinese probiotics manufacturer China-Biotics
So what: If China-Biotics bulls are looking for somebody to shake their fists at today, it's TheStreet.com's Rick Pearson. Pearson penned an extended commentary discussing his recent visits to China-Biotics facilities and his decision to stay "extremely short" China-Biotics shares.
Now what: At this point, not much surprises me when it comes to Chinese small caps and I've decided to steer clear of the group altogether. Pearson's rundown of China-Biotics sounds pretty par for the course when it comes to Chinese companies under suspicion. In short (no pun intended), it sounds like these are lightly staffed and trafficked facilities that don't appear to be doing nearly the volume of business that the company claims. Could this be another case of smoke and mirrors? Time will tell, but you won't find my portfolio anywhere near it.
Want to keep up to date on China-Biotics? Add it to your watchlist.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Fool contributor Matt Koppenheffer does not have a financial interest in any of the companies mentioned. You can check out what Matt is keeping an eye on by visiting his CAPS portfolio, or you can follow Matt on Twitter @KoppTheFool or Facebook. The Fool’s disclosure policy prefers dividends over a sharp stick in the eye.